Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01829100 · ClinicalTrials.gov registry record · NA
Transdiagnostic Behavioral Activation Therapy for Youth Anxiety and Depression
A NA study of Anxiety Disorders and Depressive Disorder, sponsored by Rutgers University.
- Completed
- Registry status
- NA
- Development phase
- 895
- Enrollment target
- 1
- Study location
NCT01829100 is a NA study of Anxiety Disorders and Depressive Disorder that has completed, run by Rutgers University. The registered enrollment target is 895 participants, below the 1,129-participant average among 84 other Anxiety Disorders trials with a reported enrollment target (21% lower). The trial reports 1 study location across 1 state.
The verdict
NCT01829100, a NA study of Anxiety Disorders and Depressive Disorder, has completed, sponsored by Rutgers University.
- COMPLETED
- Registry status
- NA
- Development phase
- 895 participants
- Enrollment target
- 1
- Study location
Study Summary
Psychological therapies for depression have demonstrated efficacy, but outcomes are still unsatisfactory, especially in cases with high comorbidity. Depression and anxiety co-occur in up to 69-75% of teens and intensify functional impairment and service use. This study will develop treatment materials for a transdiagnostic Group Behavioral Activation Therapy (GBAT) and conduct a pilot waitlist-controlled school-based study with 35 7th and 8th grade boys and girls with co-occurring depression and anxiety. Multi-reporter, multi-domain assessments will be conducted at initial screening, pre- and post-treatment, and 4-month follow-up. BA is a straightforward, but flexible and robust, therapy that has demonstrated strong results in adults. Current formulations of BA highlight the specific role of avoidance in depressotypic behavior. It presumes that anhedonia, isolation, and negative behaviors associated with depression function to avoid imminent distress even as it blocks access to otherwise available positive reinforcement. This study will therefore employ novel electronic diary technology to obtain Ecological Momentary Assessment and evaluate: (a) the function of avoidance in distinguishing youth with depression (n=35) from a non-clinical comparison group (n=18), and (b) the role of avoidance in mediating treatment gains in participants in the GBAT intervention.
Conditions Studied
Interventions
- BEHAVIORAL Group Behavioral Activation Therapy (GBAT)
Study Locations (1)
New Jersey
- Rutgers University - Piscataway
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 895 participants |
| Start Date | 2009-09 |
| Est. Completion | 2012-06 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01829100
The ClinicalTrials.gov registry entry for NCT01829100 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 895 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,129-participant average among 84 other Anxiety Disorders trials with a reported enrollment target (21% lower). The listed sponsor is Rutgers University, which has 18 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Anxiety Disorders appearing as the primary indexed condition, and to 1 intervention - of which Group Behavioral Activation Therapy (GBAT) is the first listed.
NCT01829100 reports 1 study location spanning 1 distinct geographic area - top geographies include New Jersey.
Frequently Asked Questions
What is clinical trial NCT01829100 about?
NCT01829100 is a clinical study titled "Transdiagnostic Behavioral Activation Therapy for Youth Anxiety and Depression". Psychological therapies for depression have demonstrated efficacy, but outcomes are still unsatisfactory, especially in cases with high comorbidity. Depression and anxiety co-occur in up to 69-75% of teens and intensify functional impairment and service use. This study will develop treatment materia...
What is the current status of trial NCT01829100?
This trial is currently completed. It is a NA study. The enrollment target is 895 participants. The study started on 2009-09. Estimated completion is 2012-06.
What conditions does trial NCT01829100 study?
This clinical trial studies the following conditions: Anxiety Disorders, Depressive Disorder.
What interventions are being tested in trial NCT01829100?
The interventions under investigation include: Group Behavioral Activation Therapy (GBAT) (BEHAVIORAL).
Who is sponsoring clinical trial NCT01829100?
This trial is sponsored by Rutgers University, which has 18 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01829100 being conducted?
This trial has 1 study location across New Jersey. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Anxiety Disorders
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Pilot Effectiveness Trial of an ACT Self-help Workbook Tailored Specifically for Prisons
RECRUITING · NA
-
CRISOL Mente: A Multilevel Community Intervention to Reduce Mental Health Disparities Among Latinos
RECRUITING · NA
-
Initial Assessment of the Feasibility and Efficacy of a Scalable Digital CBT for Generalized Anxiety and Associated Health Behaviors in a Cardiovascular Disease Population
RECRUITING · NA
-
Managing Anxiety in Pediatric Primary Care (MAPP)
RECRUITING · NA
-
DINO RCT - Treating Anxiety in Children With Autism
RECRUITING · NA
-
Development of a Transdiagnostic Intervention for Adolescents at Risk for Serious Mental Illness
RECRUITING · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.